Mark Collingbourne

Mark Collingbourne is currently serving as the Chief Financial Officer in multiple companies including Probiotix Health PLC, Cytomos, Intuitive Investments Group PLC, OptiBiotix Health PLC, Morrison Kingsley Consultants, and ELM Group. With a background in Accounting from the University of Stirling, Mark has extensive experience in managing finances for companies in the life sciences and biotechnology industries. Additionally, Mark has held positions such as Managing Director at Morrison Kingsley Consultants and Group Finance Director at ELM Group.